Evaluation of a thrice weekly administration of teicoplanin in the outpatient setting: a retrospective observational multicentre study.

This study supports thrice weekly teicoplanin as a convenient and effective OPAT for administration in the OPAT setting. Therapeutic drug monitoring is advised to adjust for intra-patient variability.